全文获取类型
收费全文 | 61684篇 |
免费 | 3943篇 |
国内免费 | 990篇 |
专业分类
耳鼻咽喉 | 472篇 |
儿科学 | 1570篇 |
妇产科学 | 1592篇 |
基础医学 | 7312篇 |
口腔科学 | 1078篇 |
临床医学 | 5532篇 |
内科学 | 14404篇 |
皮肤病学 | 1142篇 |
神经病学 | 5591篇 |
特种医学 | 1982篇 |
外国民族医学 | 2篇 |
外科学 | 7706篇 |
综合类 | 2149篇 |
现状与发展 | 1篇 |
一般理论 | 12篇 |
预防医学 | 4080篇 |
眼科学 | 971篇 |
药学 | 5053篇 |
8篇 | |
中国医学 | 1021篇 |
肿瘤学 | 4939篇 |
出版年
2023年 | 498篇 |
2022年 | 1120篇 |
2021年 | 2149篇 |
2020年 | 1317篇 |
2019年 | 1582篇 |
2018年 | 1747篇 |
2017年 | 1368篇 |
2016年 | 1412篇 |
2015年 | 1815篇 |
2014年 | 2442篇 |
2013年 | 3068篇 |
2012年 | 4171篇 |
2011年 | 4364篇 |
2010年 | 2520篇 |
2009年 | 2209篇 |
2008年 | 3570篇 |
2007年 | 3609篇 |
2006年 | 3351篇 |
2005年 | 3211篇 |
2004年 | 2879篇 |
2003年 | 2533篇 |
2002年 | 2317篇 |
2001年 | 1517篇 |
2000年 | 1407篇 |
1999年 | 1333篇 |
1998年 | 578篇 |
1997年 | 442篇 |
1996年 | 428篇 |
1995年 | 353篇 |
1994年 | 320篇 |
1993年 | 259篇 |
1992年 | 713篇 |
1991年 | 605篇 |
1990年 | 571篇 |
1989年 | 580篇 |
1988年 | 484篇 |
1987年 | 436篇 |
1986年 | 417篇 |
1985年 | 333篇 |
1984年 | 279篇 |
1983年 | 230篇 |
1982年 | 131篇 |
1981年 | 109篇 |
1979年 | 220篇 |
1978年 | 137篇 |
1977年 | 118篇 |
1974年 | 128篇 |
1973年 | 130篇 |
1972年 | 129篇 |
1971年 | 112篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
62.
慢性鼻窦炎鼻息肉合并支气管哮喘患者鼻窦内镜术后对支气管哮喘疗效的影响 总被引:13,自引:0,他引:13
目的观察鼻窦内镜术(endoscopic sinu ssurgery,ESS)对慢性鼻窦炎伴支气管哮喘患者哮喘发作的影响。方法对210例慢性鼻窦炎患者施行ESS术,其中伴有支气管哮喘病史者42例(20.0%)。210例患者均于术前、术后采用酶联免疫吸附测定法(ELISA)检测外周血单个核细胞(PBMC)培养上清液中的白细胞介素4(IL-4),干扰素γ(IFN-γ),可溶性白细胞介素2受体(sIL-2R)和可溶性IgE低亲和力受体(solube CD23,sCD23)的含量,并与20例正常对照组进行比较。通过主观和客观标准评定42例患者哮喘发作及对皮质类固醇的耐受状况,并对术后患者进行为期1年(10例)和3年(32例)的随访。结果鼻窦炎合并支气管哮喘患者术前PBMC培养上清液中IL-4,sIL-2R、sCD23含量较对照组显著升高,而IFN-γ含量较对照组显著减少。术后IL-4、sIL-2R、sCD23含量较对照组显著降低,而IFN-γ含量显著增高。术后哮喘改善水平由随访术后1年的45%提高到术后3年的70%。42例中32例(76%)哮喘发作次数明显减少,术前长期服用类固醇的2l例中,14例(67%)减少了对口服类固醇的使用。结论ESS对慢性鼻窦炎伴支气管哮喘患者的治疗有较满意的远期疗效。ESS能调节IL-4、IFN-γ sIL-2R、sCD23水平,降低哮喘的发作频率和对类固醇的依赖。 相似文献
63.
Stefano Di Domenico Giulio Bovio Maximiliano Gelli Ferruccio Ravazzoni Enzo Andorno Damiano Cottalasso Umberto Valente 《BMC surgery》2007,7(1):18
Background
Liver transplantation in presence of diffuse portal vein thrombosis is possible by using caval blood as portal inflow, through cavo-portal transposition. However, clinical results are heterogeneous and experimental studies are needed, but similar hemodynamic conditions are difficult to obtain, especially in small animals. Herein we describe a new simple model of cavo-portal transposition in rat. 相似文献64.
65.
66.
Vincenzo Neri Antonio Ambrosi Giuseppe Di Lauro Tiziano Pio Valentino 《JSLS, Journal of the Society of Laparoendoscopic Surgeons》2006,10(1):66-69
OBJECTIVES: The aim of this study was to evaluate the safety and effectiveness of laparoscopic-assisted sigmoid colectomy for diverticulitis and to assess its postoperative advantages. METHODS: From 1999 to 2001, 5 patients were selectively operated on with a laparoscopic-assisted procedure for uncomplicated sigmoid diverticulitis. In the preceding period (September 1997 through December 1998), 4 patients underwent open procedures for the same pathology. The surgical indication with the same criteria was restrictive: at least 2 acute episodes had occurred that were treated with hospital admission and that were separated by an adequate period (2 months) of medical therapy. RESULTS: No conversions of laparoscopy to an open procedure were necessary. Age, sex, weight, morbidity, and mortality were similar between the 2 groups. Operative time was 180 minutes for laparoscopy and 120 minutes for laparotomy. Postoperative resumption of peristalsis was 24 hours versus 4 days, resumption of alimentation was on the second postoperative day versus the fifth postoperative day, and hospital stay was 7 days versus 12 days for laparoscopy and laparotomy, respectively. CONCLUSION: This study shows the feasibility and the advantages of elective laparoscopic-assisted colonic resection for uncomplicated sigmoid diverticulitis. The advantages of the laparoscopic approach are the lower need for analgesics and the more precocious ambulation, canalization, resumption of alimentation, and the shorter hospital stay. 相似文献
67.
68.
69.
70.
Laura Cisneros Maria-Carlota Londo?o Carmen Blasco Ramón Bataller Rosa Miquel Miquel Bruguera Pere Ginès Antoni Rimola 《Liver transplantation》2007,13(7):1017-1027
The pathogenic mechanisms of accelerated graft fibrosis in hepatitis C recurrence after liver transplantation (LT) are not well established. The aim of the study was to assess whether a greater activation of hepatic stellate cells (HSC), the major collagen-producing cells in the liver, can occur in these patients as compared to non-LT patients with chronic hepatitis C. We determined the amount of activated HSC by computer-based morphometric analysis of alpha-smooth muscle actin (alphaSMA)-positive cells and the hepatic TGFbeta(1) expression by immunohistochemistry in 46 LT patients with hepatitis C recurrence, 35 non-LT patients with chronic hepatitis C, and 16 controls. Hepatic alphaSMA and TGFbeta(1) expression was higher in LT patients with hepatitis C recurrence than in controls and was correlated with fibrosis stage and progression rate. No significant difference in alphaSMA and TGFbeta(1) expression was observed between LT and non-LT patients with hepatitis C, with the exception of a higher transforming growth factor beta-1 (TGFbeta(1)) expression in non-LT patients in the early stages of fibrosis. LT patients receiving cyclosporine (CsA) or tacrolimus (FK) had a similar fibrosis progression rate and alphaSMA and TGFbeta(1) expression. In conclusion, the accelerated fibrosis observed in LT patients with hepatitis C recurrence does not seem to be related to a greater amount of activated HSC and TGFbeta(1) expression in the grafts of these patients as compared to non-LT patients with chronic hepatitis C. In LT patients, the amount of activated HSC and TGFbeta(1) expression correlated with fibrosis stage and progression, without any apparent influence of the type of calcineurin inhibitor administered. 相似文献